Robert W. Carling - Concepedia

Author

Robert W. Carling

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Carling, R., Carling, Robert W.; Koning, Patricia Brady, Carling, Robert Weaver, R Carling, R W Carling, R. Carling, R. W. CARLING, R. W. Carling, R.W. Carling, R.W.C. Carling

106

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)MSD (UK) Limited (United Kingdom)Sandia National Laboratories California

About

Robert W. Carling is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	2K
2	Natural Sciences	14	17	841
3	Engineering	12	16	464
4	Social Sciences	2	2	1K
5	Allergy	1	1	47

Robert W. Carling

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype Ruth M. McKernan, T.W. Rosahl, David S. Reynolds, Nature Neuroscience Molecular PharmacologyPsychiatryNeurophysiologyMedicinePsychotropic Medication	2000	935
4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor Paul D. Leeson, Robert W. Carling, Kevin W. Moore, Journal of Medicinal Chemistry	1992	187
TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2 H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an Agonist Selective for α2- and α3-Containing GABAA Receptors, Is a Nonsedating Anxiolytic in Rodents and Primates John Atack, Keith A. Wafford, Spencer J. Tye, Journal of Pharmacology and Experimental Therapeutics	2005	187
Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor Paul D. Leeson, R. BAKER, Robert W. Carling, Journal of Medicinal Chemistry	1991	144
3-Phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-<i>a</i>]phthalazines and Analogues: High-Affinity γ-Aminobutyric Acid-A Benzodiazepine Receptor Ligands with α2, α3, and α5-Subtype Binding Selectivity over α1 Robert W. Carling, Kevin W. Moore, Leslie J. Street, Journal of Medicinal Chemistry Lead IdentificationOrganic ChemistryPharmacotherapyChemical BiologyPharmaceutical Chemistry	2004	135
Effect of Plasma Protein Binding on in Vivo Activity and Brain Penetration of Glycine/NMDA Receptor Antagonists Michael Rowley, Janusz J. Kulagowski, Alan P. Watt, Journal of Medicinal Chemistry Brain PenetrationGlycine/nmda Receptor AntagonistsPharmacotherapyExperimental PharmacologyHplc Assay	1997	129
An Orally Bioavailable, Functionally Selective Inverse Agonist at the Benzodiazepine Site of GABA<sub>A</sub> α5 Receptors with Cognition Enhancing Properties Mark S. Chambers, John Atack, Robert W. Carling, Journal of Medicinal Chemistry Psychotropic MedicationNeurotransmitterPsychopharmacologyInverse AgonistPharmacotherapy	2004	107
Selective, Orally Active γ-Aminobutyric Acid <sub>A</sub> α5 Receptor Inverse Agonists as Cognition Enhancers Francine Sternfeld, Robert W. Carling, Richard A. Jelley, Journal of Medicinal Chemistry	2004	104
2-Carboxytetrahydroquinolines. Conformational and stereochemical requirements for antagonism of the glycine site on the N-methyl-D-aspartate (NMDA) receptor Robert W. Carling, P D Leeson, Angela M. Moseley, Journal of Medicinal Chemistry	1992	100
3-Nitro-3,4-dihydro-2(1H)-quinolones. Excitatory amino acid antagonists acting at glycine-site NMDA and (RS)-.alpha.-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors Robert W. Carling, Paul D. Leeson, Kevin W. Moore, Journal of Medicinal Chemistry -.Alpha.-amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid ReceptorsPharmacotherapyChemical BiologyExperimental PharmacologyPharmaceutical Chemistry	1993	94

Page 1